CHICAGO, March 11, 2019 (GLOBE NEWSWIRE) — United American Healthcare Corporation (OTC: UAHC), an emerging technology holding company, today announced its wholly-owned subsidiary American Sustainable Rubber Company, LLC (“ASR”), an indoor agriculture technology company focused on creating a domestic solution for natural rubber production, has been assigned grant funding from The Ohio State University SEEDS: Research Enhancement Competitive Grants Program at The Ohio Agricultural Research and Development Center, to further its research on the genetic modification of the Taraxacum Kok-saghyz (TK) dandelion plant as a viable alternative source of natural rubber to Hevea brasiliensis (rubber tree).
The grant was originally awarded to Dr. Katrina Cornish, who was recently announced as scientific advisor to ASR, and ASR President, Timothy J. Madden, after submission of their collaborative proposal entitled “Improving Natural Rubber Yield in TK Dandelion: Demonstration of a novel, rapid crop improvement technology in rubber dandelion”. As part of the grant, ASR has provided matching funds to Dr. Cornish and The Ohio State University.
“This is the first step in what we believe will be a long and prosperous relationship with The Ohio State University and its College of Food, Agricultural, and Environmental Sciences,” said Timothy J. Madden, President of American Sustainable Rubber. “Dr. Cornish and our team have been working on this research for several years and we intend to use this funding to add a graduate student to our research and development team. This additional team member will help assist in Dr. Cornish’s genetic modification research to demonstrate gene editing pathways that increase the transient efficiency of the TK dandelion plant to consistently deliver higher natural rubber yields.”
For more information on the new, wholly-owned subsidiary, please visit AmericanRubber.com. Additionally, interested parties can subscribe for updates and more information.
About American Sustainable Rubber Company, LLC
American Sustainable Rubber Company, LLC is an indoor agriculture firm pursuing proprietary technology to sustainably produce natural rubber in the United States at a commercial scale from the genetically modified TK dandelion plant.
About United American Healthcare Corporation
United American Healthcare Corporation (“UAHC”), through its subsidiary UAHC Ventures, LLC, pursues strategic investment opportunities in various emerging growth industries. UAHC subsidiary Pulse Systems, LLC, is a contract manufacturing company that provides services to the medical device industry and American Sustainable Rubber Company, LLC (“ASR”), is an indoor agriculture technology company focused on creating a domestic solution to natural rubber production.
Forward Looking Statement:
Certain information set forth in this press release contains forward-looking statements, the achievement or success of which involves risks, uncertainties, and assumptions. These statements are not guaranteeing of future performance and undue reliance should not be placed on them. If any such risks or uncertainties materialize or if any of the assumptions proves incorrect, the results of the company could differ materially from the results expressed or implied by the forward-looking statements we make. Some of the forward-looking statements include market demand information, expected development of the business, execution of the vision and growth of the company, completion of its projects, and the renewal of certain licenses and supplier relationships. Forward-looking statements are provided to allow potential investors the opportunity to understand management’s beliefs and opinions in respect of the future so that they may use such beliefs and opinions as one factor in evaluating an investment.
Some of the specific risks and uncertainties involved in the company’s business plan include, but are not limited to, the following: (i) the possibility that the company will not achieve its objective of becoming a leading provider of natural rubber through the further development of the TK dandelion for such purposes; (ii) the commercialization of alternative technological advancements that could render the company’s solutions less valuable in the marketplace; (iii) the failure of the company to successfully develop and commercialize the technology that it licenses; (iv) the inability of the company to obtain the financing it needs to carry out its business plans; (v) the inability of the company and its partners to modify the TK dandelion to a point where it contains enough natural rubber to make a commercially viable product; (vi) a market shift away from natural rubber to synthetic rubber or other substitutes; (vii) the development by competitors of alternative ways to produce natural rubber that render the dandelion approach comparatively ineffective; (viii) challenges based on intellectual property claims could be brought against the company or its licensor; and (ix) other market factors, including without limitation, macroeconomic, regulatory, tax policy, cyber security, currency, climate change, international trade and geopolitical risks.
Although forward-looking statements contained in this press release are based upon what management of the company believes are reasonable assumptions, there can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. The company undertakes no obligation to update forward-looking statements if circumstances or management’s estimates or opinions should change except as required by applicable securities laws. The reader is cautioned not to place undue reliance on forward-looking statements.
Any unreleased services or features referenced in this or other presentations, press releases or public statements are not currently available and may not be delivered on time or at all. Customers who purchase our services should make their purchase decisions based upon features that are currently available.
Public Relations Contact:
Investor Relations Contact:
+1 844 877 7700